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1. Introduction 
The discovery of viruses is tightly linked to the most significant advances in Molecular cell 
biology, including cancer research. Cell division is a fundamental biological phenomenon, 
therefore it is not surprising that human cancer is an evolutionarily ancient disease, that 
attracted attention in early civilizations. The remains of a 4 million-old fossilized hominid 
show evidence of bone tumors (Diamandopoulos, 1996), while some of the oldest written 
accounts of cancer are recorded in the code of Hamourabi (1750 BCE), Egyptian papyri (1600 
BCE) and others. Unfortunately, in ancient Egypt knowledge was the realm of priests, so the 
writings of the time attributed the etiology of disease to the “will of Gods”. In ancient 
Greece, medicine was freed from the bonds of religion; Hippocrates (460-370 BCE) tried to 
use logical thinking to propose the humoral theory of cancer and his ideas influenced 
philosophers and scientists for the next ~1,800 years. During this time, knowledge of 
Mathematics and Physics was remarkably advanced; the acoustics of amphitheaters, built in 
the 5th century BC are as good as the best of today’s structures. Still, these amazing minds 
believed in spontaneous generation of life, a theory that lasted till Louis Pasteur (1822-1895) 
who demonstrated that living things cannot be generated automatically (Javier and Butel, 
2008).  
In 1892 Ivanofsky and Beijerinck became the fathers of the new field of Virology by showing 
that an infectious pathogen of tobacco plants, the Tobacco Mosaic agent, retained infectivity 
after passage through filters of unglazed porcelaine, known to retain bacteria (Levine, 2001). 
These landmark discoveries were quickly followed by the discovery of the first cancer 
viruses, the chicken leukemia virus by Ellerman and Bang in 1908, and the Rous Sarcoma 
virus in 1911. Since that time, virus research and cancer research have been closely 
integrated, since complicated biological problems that constitute the basic mechanisms of 
life are highly conserved, since they cannot change radically once solved by evolution. As 
viruses need to use the molecular machinery of the host to replicate, they have provided us 
with valuable tools to study the host, including mechanisms of cellular replication, ie cancer. 
Historically, two classes of viruses, the retroviruses and DNA tumor viruses have been 
involved in landmark discoveries in cancer, and have played a fundamental role as models 
in molecular biology, as well as experimental cancer research.  
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Early work by Sarah Stewart and Bernice Eddy demonstrated that the mouse polyoma virus 
produced in cell culture could cause tumors upon injection in newborn hamsters (Eddy et 
al., 1958). Soon thereafter, Vogt and Dulbecco developed tissue culture methods and it was 
shown that it could transform normal, cultured cells to acquire properties of cells derived 
from polyoma virus-induced tumors, such as growth to many layers, growth in the absence 
of anchorage to a solid support and tumorigenicity in syngeneic animals (Vogt and 
Dulbecco, 1960). At the same time, Simian Virus 40 (SV40) gained notoriety because it was 
found by Eddy to be a contaminant of poliomyelitis and adenovirus vaccines, which had 
been administered to millions of healthy individuals worldwide. The public health 
implications of this revelation provided the initial impetus for an in depth study of SV40 
biology. Later work showed that SV40 DNA sequences as well as infectious virus are in fact 
found in human tumors and may have contributed to oncogenesis. The fact that SV40 uses 
mostly cellular machinery to carry out important steps in viral infection, made it into a 
powerful probe to examine many fundamental questions in eukaryotic molecular biology.  
In addition to their importance in cell biology, due to their potent transforming ability, DNA 
tumor viruses have been studied extensively. In fact, work on the mechanism of neoplasia 
caused by these viruses has yielded a plethora of information on cell growth controls and 
led to the discovery of two families of antioncogenes, p53 and the retinoblastoma 
susceptibility (Rb) gene products. 
2. Replication of DNA tumor viruses 
The DNA tumor viruses belong in the papova (the name is derived from papilloma, 
polyoma, Simian vacuolating viruses) or adenovirus families. They all have non-enveloped 
particles and both groups are highly tumorigenic in experimental animals.  
Polyoma viruses cause disease in a variety of species, with a very limited host range. The 
prototype of this group is the mouse polyoma virus, but three polyomaviruses have also 
been described in humans: JCV, the etiologic agent of progressive, multifocal 
leucoencephalopathy, a fatal demyelinating disease, BKV, causing nephropathy in 
immunocompromised individuals, (Hirsch, 2005) and SV40, the contaminant of polio 
vaccines, whose prevalence in humans is not clear (Garcea and Imperiale, 2003).  
The response of cultured cells to DNA tumor virus infection depends upon the species being 
infected. In the case of SV40, monkey cells support the production of infectious virus, which 
leads to their death (lytic cycle), whereas rodent cells produce only the early proteins, ie the 
proteins expressed before viral DNA replication has commenced in a lytic infection, and 
acquire a neoplastically transformed phenotype. Similarly, polyoma virus grows lytically in 
mouse cells but transforms rat or hamster cells in culture.  
Viruses of the polyoma family have circular dsDNA genomes of approximately 5,000bp, 
contained in icosahedral capsids. Their genome contains two coding regions, the early 
genes, expressed before viral DNA replication in a lytic infection, and the late genes which 
are expressed after viral DNA replication is underway. Both transcription units are 
regulated by a common non-coding control region that contains the transcription start sites, 
binding sites for the transcription factors and the origin of DNA replication. The early 
region encodes the alternatively spliced transforming proteins large T (or Tumor)-antigen 
and small t-antigen, while the mouse polyoma virus also expresses a 56kDa middle tumor 
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antigen, which is its main transforming protein. The late genes encode mostly structural coat 
proteins (VP1, VP2, VP3, Figure 1). 
 
Fig. 1. Genomic organisation of the 5297 bp mouse polyoma virus. The early region is at the 
right and the late region at the left. The transcriptional enhancer and origin of DNA 
replication are also shown. Soon after infection, the differentially spliced, early genes (T 
antigens) are expressed (right side), followed by replication of viral DNA. After DNA 
replication, the late genes are expressed (left), coding mostly for the structural proteins, VP1, 
VP2, VP3. Squiggly lines indicate the introns (Cole, 1995).  
In the host species, polyomaviruses spread by lytic infection of permissive cells. Lytic 
infection requires the large T-antigen, a ~100 kDa nuclear phosphoprotein which binds the 
origin and is essential for viral DNA replication [reviewed in (Cole, 1995)]. Polyomaviruses 
rely on cellular enzymes for the replication of their DNA, since their genome does not code 
for replication proteins. These proteins are confined to the S phase of the cell cycle, and the 
large T-antigens modulate cellular signaling pathways by interacting with a plethora of 
cellular proteins that promote cell cycle progression into S phase. Due to this property, the 
large T-antigens are also important players in the transformation of virus-infected cells. The 
most well-known interaction is the ability of the T-antigens to associate with, and interfere 
with the functions of the two tumor suppressor proteins, pRb and p53. 
In non-permissive, cultured cells infection is abortive and neoplastic transformation of the 
cell may occur. Transformation requires expression of the early region, in particular the 
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large T-antigen in the case of the human polyoma viruses (Fig. 1). The mouse polyoma 
middle-tumor antigen associates with and activates the cellular Src protein, but its large T 
antigen is also important in viral DNA replication, as well as transformation in certain 
systems. The tumor antigens are also key players in the highly efficient oncogenesis in vivo 
by these viruses, ie when virus is inocculated into animals or when the early region is 
introduced into transgenic mice. 
Adenoviruses have linear dsDNA’s of approximately 35,000bp enclosed in icosahedral 
particles with spikes on the vertices.The human adenoviruses infect and can grow lytically 
in human cells but can cause tumors in rodents and transform a variety of rodent cells in 
culture. Their genome is linear, double-stranded DNA of ~35,000 bp with a number of 
transcription units. Early after infection at least four promotors are activated (E1, E2, E3, E4), 
while at late times there is activation of the major late promotor, coding mostly for a number 
of coat proteins (Fig. 2). The adenovirus early region E1A and E1B genes are important in 
transformation of cultured cells and tumorigenicity, but E1A is also required in a lytic 
infection, for the transactivation of all other Adenoviral genes. E1A proteins bind the Rb 
family, while E1B associates with and inactivates p53. The adenoviruses display extensive 
RNA splicing, therefore it is not surprising that splicing was discovered for the first time in 
adenoviruses [(Broker, 1984), reviewed in (Shenk, 1995)].  
 
Fig. 2. Transcription and translation map of adenovirus type 2. The early mRNAs are 
designated E, late mRNAs are designated L. The main genes involved in transformation are 
the E1A and E1B at the left of the genome, giving rise to several proteins with differential 
splicing (not shown). (From Broker, 1984).  
r-strand: rightwards transcribed, l-strand, leftwards transcribed.  
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The papillomaviruses comprise a group of nonenveloped DNA viruses that induce mostly 
benign lesions of the skin (warts) and mucous membranes (condylomas) in humans and 
animals. However, some members such as human papilloma viruses 16 and 18 have been 
implicated in the development of epithelial malignancies, especially cancer of the uterine 
cervix and other tumors of the urogenital tract. The papillomaviruses are small, 
nonenveloped, icosahedral DNA viruses that replicate in the nucleus of squamous epithelial 
cells. The virion has a single molecule of double-stranded, circular DNA of approximately 
8,000 base pairs. The E6 and E7 are the main oncogenes of the high-risk HPVs. E7 binds with 
and inactivates Rb, while E6 binds p53 and leads to its degradation (Howley and Lowy, 
2007) 
3. Interaction of the DNA tumor virus oncogenes with the retinoblastoma 
family 
The demonstration that DNA tumor viruses can cause tumors in animals led to an intensive 
investigation into the mechanism of tumor induction. The type of tumor that developed in 
an animal following viral inocculation often depended upon the site of injection; early 
findings demonstrated that injection of adenovirus-12 directly into the vitreous body of 
newborn rats, mice or baboons induced retinoblastoma-like tumors that expressed 
adenovirus gene products (Kobayashi and Mukai, 1973; Mukai et al., 1977; Mukai et al., 
1980; Kobayashi et al., 1982). However, no adenovirus or JC polyoma virus was ever found 
in human retinoblastomas. Still, adenovirus research and the development of monoclonal 
antibodies against the tumor antigens of these viruses greatly facilitated the identification of 
cellular proteins specifically binding to the viral oncogenes. One of them was the Rb gene 
product, whose inactivation was independently demonstrated to lead to retinoblastoma 
formation in humans.  
Seminal studies on retinoblastoma by Knudson et al (Knudson, Jr., 1971) laid the foundation 
for the tumor suppressor hypothesis. Statistical analysis of age and family history made him 
conclude that two independent mutation events are required for retinoblastoma 
development. It was later proposed that the two mutations occurred in the two alleles of the 
same gene, Rb1 that is, retinoblastoma is a recessive cancer where one abnormal 
chromosome was inherited, while the corresponding, wild-type chromosomal segment was 
lost in the tumor cells (Godbout et al., 1983; Benedict et al., 1983). Genetic linkage studies 
demonstrated anomalies on chromosome 13q14, close to the esterase D locus (Sparkes et al., 
1983). Cloning of the retinoblastoma cDNA followed and it was shown that it encodes a 110 
kDa nuclear phosphoprotein (Lee et al., 1987). Additional studies showed that the Rb1 gene 
from retinoblastoma tumors had deletions and mutations, consistent with a model where 
gene inactivation ie loss of function leads to tumor formation [reviewed in (Burkhart and 
Sage, 2008)].  
Several groups tried to identify cellular proteins that bind to the E1A gene products. 
Branton et al developed a series of anti-peptide antisera and identified several co-
immunoprecipitated proteins, including a doublet of approximately 105 kDa (Yee and 
Branton, 1985). Most importantly, these proteins could be affinity-purified from uninfected 
cells using E1A expressed in bacteria. This observation indicated that the 105 kDa protein(s) 
was of cellular, rather than viral, origin. Moreover, their expression did not depend upon 
adenovirus infection, or expression of any viral proteins (Egan et al., 1988). It was further 
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shown that residues 111-127 and 30-60 of E1A were required for binding to the 105 kDa 
protein (Egan et al., 1988). A breakthrough finding followed: A monoclonal antibody was 
raised using as an immunogen E1A that had been immunoprecipitated from E1A-
expressing, 293 cells, therefore potentially containing cellular proteins bound to E1A. As it 
turned out, this antibody recognised the 105kDa, Rb protein. These data demonstrated that 
the Rb was, in fact, the 105 kDa, cellular protein associated with E1A. This observation 
offered the first demonstration of a physical association between an oncogene and an 
antioncogene (Whyte et al., 1988; Lee et al., 1987). Similar findings emerged on the SV40 
system (DeCaprio et al., 1988). Most importantly, it was soon demonstrated that TAg 
mutants that were unable to transform, were unable to bind Rb (e.g. E107K). These mutants 
disrupted the sequence LxCxE, the site of Rb binding which is present in the large TAg’s of 
both SV40 and polyoma, adenovirus E1A, the human papillomavirus E7 proteins, as well as 
the TAg’s of several other human polyoma viruses (Munger et al., 1989; Dyson et al., 1989). 
Taken together, these findings demonstrated the cardinal importance of Rb binding in 
transformation by these oncogenes [reviewed in (DeCaprio, 2009)].  
Examination of Rb’s function demonstrated that Rb is unphosphorylated in quiescent (G0) 
cells, but its phosphorylation increases as cells progress in the cell cycle (Buchkovich et al., 
1989). It was later found that it is the cyclin D/Cdk4, cyclin E/Cdk2, cyclin A/Cdk2 and 
cyclin B/cdc2 kinases, shown to be required for entry into the cell cycle, that phosphorylate, 
and thereby inactivate Rb (DeCaprio et al., 1992). It was also demonstrated that the SV40-
TAg binds the under- or unphosphorylated form of Rb exclusively (Ludlow et al., 1990), 
which suggested that the G0 form of Rb served a growth-suppressive function, which was 
overcome by TAg. In addition, overexpression of Rb inhibits cell cycle progression from G1 
to S (Goodrich et al., 1991). Finally, transgenic expression of SV40-TAg under control of 
luteinizing hormone-┚ induces retinoblastomas and TAg co-precipitated Rb in lysates from 
tumor cells, supporting the hypothesis that retinoblastoma can develop by the inactivation 
of Rb function by TAg (Windle et al., 1990).  
Thus, the loss of the Rb growth suppressive function can be achieved by: 1. mutation 
(retinoblastomas), 2. phosphorylation (cell cycle), or 3. binding to viral oncogenes. It was 
later shown that two Rb-related proteins that also exhibit features of cell-cycle regulators, 
p107 and p130, can also bind the LxCxE sequence of E1A and TAg (Ewen et al., 1992; 
Dumont and Branton, 1992).  
Several laboratories have mapped the Rb sequences required for binding the LxCxE 
sequence. In fact, the two thirds, C-terminal region of Rb can bind E1A and TAg, and it is 
referred to as the large-pocket, while the central part of Rb (379-792) constitutes the small 
pocket (Kaelin, Jr. et al., 1990; Hu et al., 1990) (Fig. 3). The central part of Rb was the site of 
mutations in retinoblastomas, and these forms also failed to bind E1A and TAg. This 
observation offers a strong correlation between loss of binding to the oncogene to loss of 
function (Kaelin, Jr. et al., 1990; Pietenpol et al., 1990). That is, the viral oncogenes were 
found to disrupt a normal function of Rb, that was necessary for tumor suppression.  
Further studies on the mechanism of tumor suppression by Rb and transformation by these 
oncogenes led to the search for cellular proteins that could compete with TAg and E1A for 
Rb binding. One of these protein families is the E2F transcription factors. In fact, the 
hypophosphorylated form of Rb binds E2F and using Rb affinity columns it became clear  
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Fig. 3. A) The human pRb consists of 928 aminoacids. Deletion mutagenesis, as well as 
structural studies have uncovered regions that mediate its binding to individual partners. Most 
of them bind the pocket region. The Rb C-terminus binds specifically to E2F1 and this inhibits 
apoptosis. Rb can also be phosphorylated by CDK kinases as well as CHk2 (checkpoint 
homologue 2) and Raf 1 and this inhibits binding of most partners (Burkhart and Sage, 2008). 
SKP2: S-phase kinase-associated protein-2; SUV39H1: methyltransferase, methylates lysine 9 of the 
amino terminus of histone H3; DNMT1: DNA methyltransferase-1; HDAC: histone deacetylase;  
CDH1: cadherin-1 
 
Fig. 3. B) Three-dimensional structure of the Rb/E2F complex. The helices of the A domain 
are shown in red and the B domain in blue. The main-chain trace of E2F is shown as a 
yellow worm (upper panel), while the main-chain trace of the papillomavirus E7 is shown 
as a green worm (lower panel) (Xiao et al., 2003).  
www.intechopen.com
Retinoblastoma – An Update on Clinical,  
Genetic Counseling, Epidemiology and Molecular Tumor Biology 
 
162 
that the viral oncogenes (E1A, TAg, E7) dissociate Rb from E2F (Chellappan et al., 1992; 
Chellappan et al., 1991). Rb binding correlated with repression of E2F transcriptional 
activity (Hiebert et al., 1992), and overexpression of E2F1 could promote entry into S phase 
in a manner similar to adenovirus E1A (Johnson et al., 1993). Therefore, the prevailing 
model is that E1A could serve to dissociate Rb from E2F, while the conserved LxCxE motif 
plays an important role in the high affinity binding of the viral oncoproteins to Rb. In fact, a 
minimal peptide of 9 residues corresponding to the LxCxE motif of HPV16-E7 could 
compete with Rb binding to E2F and to DNA (Jones et al., 1992). There is also evidence that 
TAg and E1A recruit the CBP/p300 histone acetyltransferase to remodel chromatin and 
actively start transcription (reviewed in (DeCaprio, 2009), Fig. 4). 
 
Fig. 4. Effect of TAg or adenovirus E1A upon Rb.  
A. Active Rb binds the E2F/DP complex to repress transcription. B. Rb phosphorylation reduces 
binding to E2F/DP, permitting E2F activation. C. TAg or E1A binding removes Rb and permits E2F 
action. D-E: TAg or E1A can also bind the CBP/p300 histone acetyltransferase to increase gene 
expression. F. E1A can also bring Rb to CBP/p300 bound to transcription factors to repress promotors.  
The crystal structure of Rb demonstrated that the A and B domains of the small pocket are 
bound to each other and are linked with a large area of highly conserved residues located in 
the fold between them. The LxCxE motif of HPV-E7 is bound to an exposed cleft within the 
B domain. The side chains of L,C and E make direct contact to Rb, which explains their high 
degree of conservation (Fig. 3B) (Xiao et al., 2003). Still, E1A and large TAg employ a 
different activity to displace E2F from Rb. The 100, N-terminal residues of LT form a J-
domain, found in the family of DnaJ-Hsp40 molecular chaperones (Stubdal et al., 1997). The 
J domain recruits Hsc70 and activates its ATPase activity to promote chaperone activity. The 
J domain of large TAg cooperates with the LxCxE motif to dissociate Rb family members 
from E2F4 (Kim et al., 2001).  
It was also found that E2F acts in a complex with another protein, the differentiation-
regulated transcription factor-polypeptide 1 (DP1), which forms a heterotrimeric complex 
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with E2F1 and cooperates with E2F for promotor binding (Simonson and Herman, 1993). 
Since the original cloning, a large number of E2F and DP molecules have been identified 
that play a variety of roles [reviewed in (van den Heuvel and Dyson, 2008)].  
4. Other viral gene products interacting with the retinoblastoma family 
In addition to the DNA tumor viruses, viruses from other families, both DNA and RNA are 
known to interact with Rb directly. Following are some examples: 
The Hepatitis C virus is a positive-strand RNA virus, which causes persistent infections that 
can lead to hepatocellular carcinoma (HCC). The viral RNA-dependent, RNA polymerase 
NS5B forms a complex with Rb, targeting it for degradation and this increases E2F activity 
in E2F activity. NS5B contains a LxC/AxE motif which overlaps with the active site of the 
polymerase, and its interaction with and inactivation of Rb may be part of the mechanism 
whereby HCV infection leads to carcinoma (Munakata et al., 2005). 
The Hepatitis B virus (HBV) also causes hepatitis and chronic infections that can lead to 
HCC. It codes for the non-structural, HBx protein which transcriptionally represses p21 and 
p27, and binds directly to cyclin E and cyclin A, leading to cell cycle progression (Dayaram 
and Marriott, 2008). 
The Rubella virus (RV) causes developmental abnormalities and birth defects. RV is a 
positive-strand RNA virus encoding NSP90, a non-structural protein with replicase activity, 
which binds to Rb through an Rb binding motif (LPCAE). This association plays a positive 
role in the replication of the virus and it has been postulated that this contributes to RV's 
teratogenicity (Forng and Atreya, 1999). 
The human cytomegalovirus (HCMV) belongs in the Herpes family and it can cause 
developmental abnormalities. HCMV codes for UL97, a protein kinase which can 
phosphorylate and inactivate Rb in a manner similar to the cyclin-dependent kinases. 
Moreover, UL97 is not inhibited by the CDK inhibitor p21 and lacks amino-acid residues 
conserved in cdk's that permit the attenuation of kinase activity. That is, UL97 is a functional 
ortholog of the cyclin-dependent kinases that is immune from the normal cdk control 
mechanisms (Hume et al., 2008).  
The Human T-cell leukemia virus (HTLV) is the only human retrovirus shown to be the 
cause of a human cancer, adult T-cell leukemia. The Tax protein of HTLV (40kDa) is 
sufficient to transform cultured cells, and it achieves this at least in part through inhibition 
of a number of cyclin-dependent kinase inhibitors. Tax binds directly and inhibits p15 and 
p16, and it represses transcription of p18 and p19. In addition, Tax interacts with cdk4 and 
facilitates its binding to cyclin D2, leading to enhanced kinase activity, enhanced 
phosphorylation and proteasomal degradation of Rb, hence E2F activation. Tax also 
interacts with hypophosphorylated Rb directly, and this results in premature proteasomal 
degradation (Dayaram and Marriott, 2008). 
A number of plant viruses were also shown to bind to and require Rb function for 
replication. Geminiviruses are small, single-stranded DNA viruses infecting a wide range of 
plants. The viral genome is encapsidated into two joined icosahedral capsids. The beet curly 
top virus (BSCTV) codes for the C4 protein which, upon transgenic expression in Arabidopsis 
plants can increase the levels of most cyclins and CDK’s, CAK’s and the proliferating cell 
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nuclear antigen-1 (PCNA1). In addition, the Rb-related protein rbr1 and the CDK inhibitor 
ick1 are suppressed. Similarly, a protein of the Tomato golden mosaic virus, Rep, and the 
RepA protein of the Wheat dwarf virus are both able to bind the maize Rb-like proteins (Xie 
et al., 1995; Collin et al., 1996). Although the role of Rb in plants has not been firmly 
established, the fact that BSCTVcan induce cell division, points to the possibility that the 
effect of the C4 and Rep proteins upon Rb may be part of the mechanism of pathogenicity 
by these viruses (Park et al., 2010).  
5. Consequences of E2F activation 
Besides DNA tumor virus oncogenes, a large number of tyrosine kinases such as vSrc 
activate the E2F transcription factor indirectly, through activation of the CDK kinases. As a 
result, E2F is found to be hyperactive in many cancers. Transcriptional activation of E2F 
targets is achieved either through active transactivation or derepression of genes having 
E2F-binding sites on their promoters. A detailed Microarray analysis for E2F-activated genes 
yielded many targets, among which is a number of membrane receptor tyrosine kinases, 
such as PDGFR┙, IGF1R, VEGF, and others (Young et al., 2003). In fact, it has long been 
demonstrated that transformed cells secrete autocrine factors, able to induce anchorage-
independent growth to normal cells (Raptis, 1991; Ciardiello et al., 1990). These growth 
factors activate the membrane signalling apparatus, including the ras and phosphatidyl-
inositol-3 kinase (PI3k) cascades, as well as the signal-transducer and activator of 
transcription-3 (Stat3) pathway. Following ligand binding, Stat3 binds to receptors of 
growth factors or cytokines and is phosphorylated on tyrosine-705 by the receptor itself or 
by the associated Jak or Src kinases. Two Stat3 molecules subsequently dimerize through 
reciprocal phosphotyrosine-SH2 domain interactions, the dimer migrates to the nucleus and 
initiates transcription of a number of genes (Yu et al., 2009; Raptis et al., 2009). Both the PI3 
kinase and Stat3 constitute potent survival signals.  
As a result of E2F activation, the SV40-TAg and adenovirus E1A have both been shown to 
activate and require ras (Raptis et al., 1997) and Stat3 (Vultur et al., 2005) for neoplastic 
transformation, as well as for the block of adipocytic differentiation (Cao et al., 2007b; Cao et 
al., 2007a). However, it is particularly remarkable that at the same time E2F is a potent 
apoptosis inducer, hence the high demand of transformed cells for survival signals, normally 
offered by Stat3, activated by the growth factor receptors. Therefore, direct Stat3 inhibition 
induces apoptosis of E1A or Tag-transformed cells preferentially, due to their higher E2F 
activity levels which promotes programmed cell death through p53-dependent or 
independent mechanisms. These findings underscore the importance of Stat3 the survival of 
tumor cells, and could have significant therapeutic implications (Fig. 5).  
6. The Rb pathway in breast cancer 
Although inherited, germline mutations in the Rb gene were identified mostly in 
retinoblastomas, Rb somatic mutations, mimicking Rb inactivation by the DNA tumor viruses 
have also been noted in a number of cancers, including breast cancer, so that, despite the fact 
that no DNA tumor viruses have ever been found in breast cancer, E2F is frequently activated.  
Unlike the majority of cancers, the prognosis and treatment of breast cancer is significantly 
informed by a number of biomarkers, and the Rb pathway plays a prominent role [reviewed  
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Fig. 5. E2F, activated through Rb inactivation by viral oncogenes,  is known to be a potent 
activator of genes leading to cell division and neoplasia. Paradoxically however, E2F also 
induces apoptosis (through both p53-dependent and  -independent mechanisms), but 
apoptosis inhibition would allow cell division to occur.  In fact, E2F also activates a number of 
kinases such as IGF1-R and Src, which activate Stat3, a potent apoptosis inhibitor.  As a result, 
Stat3 inhibition in cells with high E2F levels results in apoptosis (Sears and Nevins, 2002). 
in (Musgrove and Sutherland, 2009)]. In particular, the status of the Estrogen receptor-┙ 
(ER) is an important determinant in treatment: ER-positive breast cancer has a more 
favorable prognosis and can be treated with selective ER antagonists (e.g. Tamoxifen) or 
aromatase inhibitors (e.g. Anastrozole), while ER-negative breast cancer is generally more 
aggressive, and with fewer treatment options. Still, a significant number of ER-positive 
cancers fail hormonal therapy and a great deal of effort has been expended in identifying 
pathways leading to Tamoxifen or aromatase inhibitor resistance.  
In ER-positive breast cancer treatment, ER antagonists are effective at stopping cell division, 
indicating that such tumors are dependent upon estrogen for proliferation and survival 
(Musgrove and Sutherland, 2009). It was further shown that estrogen inhibition results in 
cell cycle arrest in the G0/ G1 phase of the cell cycle through attenuation of CDK/cyclin 
complexes at multiple levels (Foster et al., 2001). In particular, cyclin D1 is a direct 
transcriptional target of ER signalling (Eeckhoute et al., 2006). On the other hand, functional 
analyses have suggested that a multitude of cascades can contribute to acquired resistance 
to endocrine therapy, such as aberant ErbB2, Grb10 or Akt signalling (Miller et al., 2009), 
while p27kip1 and Rb inactivation can compromise the efficacy of ER inhibition (Cariou et 
al., 2000; Bosco et al., 2007). Specifically, a gene expression signature of Rb-dysfunction is 
associated with luminal B breast cancer, which exhibits a relatively poor response to 
endocrine therapy. Most importantly, recent reports demonstrated that a selective CDK4/6 
inhibitor, PD-0332991 suppressed cell proliferation of a number of tamoxifen-resistant, 
cultured breast cancer cell lines. While ER antagonists in sensitive lines induce cell cycle 
arrest, CDK4/6 inhibition in tamoxifen-resistant lines induced a state having certain 
molecular characteristics of senescence in hormone therapy resistant cell populations. 
Therefore, PD-0332991 is an effective cell cycle inhibitor that could be especially valuable in 
ER+ breast cancers that are resistant to endocrine therapy, and is now being tested in phase 
II clinical trials (Thangavel et al., 2011).  
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7. Conclusions 
Results on the mechanism of transformation by DNA tumor viruses have given valuable 
insights on the role of the Rb family in cell division. Evidence is now emerging that these 
conclusions are applicable to human cancers such as cancer of the breast, hence the Rb 
pathway may offer important targets for chemotherapy. It is reasonable to assume that the 
study of the viral oncogenes will offer additional insights into the role of Rb in cancer.  
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